After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra — Novo Nordisk follows Lilly in lowering insulin prices— Pfizer CEO points to IRA as a factor that made Seagen an attractive target -- See more on our front page news http://bit.ly/w28kSd #novartis #xiidra #ophthalmology #insulin #diabetes #novonordisk #drugpricing #pfizer #mergersandacquisitions #inflationreductionact #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#novartis #xiidra #ophthalmology #insulin #diabetes #novonordisk #drugpricing #pfizer #mergersandacquisitions #InflationReductionAct #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma